GlobeImmune Inc. announced that Timothy C. Rodell has resigned his positions as the company's Chief Executive Officer and President but remains on the Board of Directors; C. Jeffrey Dekker has been appointed as the company's President, Secretary and Treasurer and been named to the company's Board of Directors; J. William Freytag, Augustine J. Lawlor, Dan J. Mitchell and S. Edward Torres have resigned from the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -99.50% | -99.50% |
1st Jan change | Capi. | |
---|---|---|
-99.50% | 5 | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.67% | 12.27B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Inc. Announces Management and Board Changes